相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event
Alessandra Casagrande et al.
NEUROENDOCRINOLOGY (2017)
Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays
Philippe Chanson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
Cristina Alvarez-Escola et al.
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2016)
Discontinuation of somatostatin analogs while acromegaly is in long-term remission
Esra Hatipoglu et al.
PITUITARY (2015)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Can we predict long-term remission after somatostatin analog withdrawal in patients with acromegaly? Results from a multicenter prospective trial
Lucio Vilar et al.
ENDOCRINE (2014)
Somatostatin receptors: From signaling to clinical practice
Marily Theodoropoulou et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2013)
Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
Claudia Ramirez et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Predictors of morbidity and mortality in acromegaly: an Italian survey
M. Arosio et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues
Marinella Tzanela et al.
CLINICAL ENDOCRINOLOGY (2011)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pituitary-independent effect of octreotide on IGF1 generation
Ana Pokrajac et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Preliminary data on biochemical remission of acromegaly after somatostatin analogs withdrawal
Cristina L. Ronchi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Mortality in acromegaly: A meta analysis
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Medical progress: Acromegaly
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2
E. Ferrante et al.
ENDOCRINE-RELATED CANCER (2006)
Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: Effects on cardiovascular risk factors
CL Ronchi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Long-acting somatostatin analog therapy of acromegaly: A meta- analysis
PU Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly
JS Bevan
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Factors influencing mortality in acromegaly
IM Holdaway et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
分享论文
